Table 1.
Clinical trials examining the effects of ashwagandha on VO2 max, sports performance and metabolic profiles.
| Participants | Dosage | Duration | Results | Reference |
|---|---|---|---|---|
| Elite athletes | 1,000 mg/day | 8 weeks | Improved the cardiorespiratory endurance | (91) |
| Elite athletes | 1,000 mg/day | 8 weeks | Improved the anaerobic capacity | (92) |
| Healthy young men engaged in resistance training | 600 mg/day | 8 weeks | Significant increases in strength and muscle mass | (93) |
| Healthy young adults | 500 mg/day | 8 weeks | Increased velocity, power and VO2 max | (94) |
| Healthy athletic adults | 600 mg/day | 8 weeks | Enhanced cardiorespiratory endurance Improved the quality of life |
(26) |
| Young hockey players | 500 mg/day | 8 weeks | Improved agility levels | (95) |
| Athletic adults | 600 mg/day | 12 weeks | Enhanced the cardiorespiratory endurance Improved quality of life | (27) |
| Hockey Players | 1,000 mg/day | 8 weeks | Improved VO2 max and hemoglobin concentrations | (96) |
| Hockey Players | 1,000 mg/day | 8 weeks | Improved Core Muscle Strength and Stability | (97) |
| Healthy participants | 600 mg/day | 8 weeks | Improved muscle strength, growth and endurance | (98) |
| Male sprinters | 2.5–3 g/day | 12 weeks | Improved standing broad jump, 50-yard dash, pull-ups, sit-ups, and shuttle run | (99) |
| Elite cyclists | 1,000 mg/day | 8 weeks | Improved the aerobic capacity | (100) |
| Healthy subjects | 12 g/day | 60 days | Improved hemoglobin and VO2 max | (101) |
| Healthy subjects | 500 mg/day | 12 weeks | Improved upper and lower-body strength | (102) |
| Healthy subjects | 20 g/day | 4 weeks | Improved Harvard Step Score and VO2 max. | (103) |